Skip to content
GCC AI Research

Search

Results for "Multiple Sclerosis"

When AI stops playing “spot the difference” and starts understanding changes in MRIs

MBZUAI ·

MBZUAI researchers presented DEFUSE-MS at MICCAI 2025, a novel AI system for analyzing changes in MRI scans of multiple sclerosis (MS) patients. DEFUSE-MS uses a deformation field-guided spatiotemporal graph-based framework to identify new lesions by reasoning about how the brain has changed. The model constructs graphs of small regions within baseline and follow-up MRIs, linking them across time with edges enriched with learned embeddings of the deformation field. Why it matters: DEFUSE-MS reframes the task from simple "spot the difference" to understanding structural changes, potentially improving the speed and accuracy of MS diagnosis and treatment monitoring.

Abu Dhabi’s AI algorithms to deliver health diagnoses in a heartbeat

MBZUAI ·

MBZUAI researchers led by Dr. Mohammad Yaqub are developing AI algorithms for real-time medical diagnoses, including tools for multiple sclerosis and congenital heart disease. The team developed ScanNav, an AI fetal anomaly assessment system licensed by GE Healthcare for Voluson SWIFT ultrasound machines. ScanNav assists doctors during anomaly scans after 20 weeks of gestation to check for conditions like heart issues and spina bifida. Why it matters: This research has the potential to significantly improve the speed and accuracy of medical diagnoses in the UAE and beyond, addressing critical gaps in healthcare.

National Multiple Sclerosis Society awards funding to 4 research projects driving multiple sclerosis research in UAE as part of 3rd cycle of Research Grant Programme - مكتب أبوظبي الإعلامي

The National ·

The National Multiple Sclerosis Society has awarded funding to four research projects aimed at advancing multiple sclerosis research within the UAE. This initiative marks the third cycle of their Research Grant Programme. The funding supports local scientists and institutions in conducting studies related to the neurological disorder. Why it matters: This commitment strengthens the UAE's capacity in medical research, fostering local scientific innovation and addressing critical health challenges in the region.